Maryland Medical Assistance Plan and Health Insurance - Pharmacogenomic Testing - Required Coverage
State of MarylandMarylandRequiring, beginning July 1, 2027, the Maryland Medical Assistance Program and certain health insurers, nonprofit health services plans, and health maintenance organizations to provide coverage for single-gene and multigene pharmacogenomic testing in certain circumstances.
- Status
- Engrossed
- Passed its first chamber
- Status date
- Mar 20, 2026
- 237 days ago
- Current chamber
- House of Delegates
- Session
- 2026 Regular Session
Follow the legislation that affects what you sell.
Get started freeFree account · 30-second setup · No credit card
What it means for vendors
Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.
Bill details
- Last action
- Hearing 4/02 at 1:00 p.m. · Mar 25, 2026
- Pending committee
- Health
Sponsor
Bill history
Newest first.
Recorded vote
Subjects
- Health - Insurance
- Health Maintenance Organizations
- Auditors and Audits
- Biotechnology
- Discipline
- Drugs
- Evaluations and Reviews
- Genetics
- Health
- Health, Department of
- Health Insurance
- Insurance Administration
- Managed Care Organizations
- Medical Assistance
- Medical Conditions
- Medical Testing and Diagnosis
- Mental and Behavioral Health
- Nonprofit Organizations
- Penalties and Sentences
- Plans and Proposals
- Time
Read the bill at the source
This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.
Bill data from LegiScan, licensed under CC BY 4.0.